|
|
·综述·
|
最新目录|
下期目录|
过刊浏览|
高级检索
|
[an error occurred while processing this directive]|[an error occurred while processing this directive] |
|
|
| 直肠癌术前IMRT技术的临床应用进展 |
| 杨咏强,朱雅群,田野 |
| 215004 苏州大学放射肿瘤治疗学研究所苏州市肿瘤放射治疗学重点实验室苏州大学附属第二医院放疗科 |
|
| Recent advances in preoperative intensity-modulated radiation therapy (IMRT) for rectal cancer |
| Yang Yongqiang,Zhu Yaqun,Tian Ye |
| Department of Radiation Oncology,Second Affiliated Hospital of Scochow University,Suzhou 215004,China |
[1]Sauer R,Becker H,Hohenberger W,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med,2004,351(17):1731-1740.DOI:10.1056/NEJMoa040694.
[2]Gérard JP,Conroy T,Bonnetain F,et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:results of FFCD 9203[J].J Clin Oncol,2006,24(28):4620-4625.DOI:10.1200/JCO.2006.06.7629.
[3]Braendengen M,Tveit KM,Berglund A,et al. Randomized phase Ⅲ study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer[J].J Clin Oncol,2008,26(22):3687-3694.DOI:10.1200/JCO.2007.15.3858.
[4]Roh MS,Colangelo LH,O′Connell MJ,et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum:NSABP R-03[J].J Clin Oncol,2009,27(31):5124-5130.DOI:10.1200/JCO.2009.22.0467.
[5]Arbea L,Ramos LI,Martínez-Monge R,et al. Intensity-modulated radiation therapy (IMRT) vs.3D conformal radio-therapy (3DCRT) in locally advanced rectal cancer (LARC):dosimetric comparison and clinical implications[J].Radiat Oncol,2010,5(1):17.DOI:10.1186/1748-717X-5-17.
[6]Hu K,Pang TT,Yang B,et al. Dosimetric analysis of preoperative three-dimensional conformal and preoperative intensity modulated radiotherapy for rectal cancer[J].Chin J Radiol Med Prot,2010,30(3):310-313.DOI:10.3760/cma.j.issn.0254-5098.2010.03.021.
[7]Mok H,Crane CH,Palmer MB,et al. Intensity modulated radiation therapy (IMRT):differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma[J].Radiat Oncol,2011,6(1):63.DOI:10.1186/1748-717X-6-63.
[8]Samuelian JM,Callister MD,Ashman JB,et al. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(5):1981-1987.DOI:10.1016/j.ijrobp.2011.01.051.
[9]Parekh A,Truong MT,Pashtan I,et al. Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer[J].Gastrointest Cancer Res,2013,6(5-6):137-143.
[10]Vazquez MD,Ferraris G,Bianchi A,et al. Clinical comparison of IMRT with 3D-CRT in preoperative chemoradiation therapy for locally-advanced rectal cancer (LARC)[J].Int J Radiat Oncol Biol Phys,2013,87(S2):S329.DOI:10.1016/j.ijrobp.2013.06.867.
[11]Garofalo M,Moughan J,Hong T,et al. RTOG 0822:A phase Ⅱ study of preoperative (PREOP) chemoradiotherapy (CRT) utilizing IMRT in combination with capecitabine (C) and oxaliplatin (O) for patients with locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2011,81(S2):S3-S4.DOI:10.1016/j.ijrobp.2011.06.008.
[12]Ren H,Jin J,Xiao Q,et al. Comparison of acute toxicities between IMRT and VMAT in preoperative concurrent chemoradiotherapy for rectal cancer[J].Chin J Radiat Oncol,2014,23(3):205-209.DOI:10.3760/cma.j.issn.1004-4221.2014.03.007.
[13]Li M,Gao H,Li GF,et al. Efficacy of preoperative concurrent chemoradiotherapy in treatment of locally advanced middle-low rectal cancer[J].Chin J Radiat Oncol,2014,23(4):286-290.DOI:10.3760/cma.j.issn.1004-4221.2014.04.003.
[14]Freedman GM,Meropol NJ,Sigurdson ER,et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2007,67(5):1389-1393.DOI:10.1016/j.ijrobp.2006.11.017.
[15]Ballonoff A,Kavanagh B,McCarter M,et al. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer:a phase Ⅱ trial[J].Am J Clin Oncol,2008,31(3):264-270.DOI:10.1097/COC.0b013e318161 dbd3.
[16]姚波,郑明民,张艳,等.低位直肠癌手术前后调强放疗同期希罗达化疗的初步比较[J].中华放射肿瘤学杂志,2010,19(1):72-73.DOI:10.3760/cma.j.issn.1004-4221.2010.01.027.
Yao B,Zheng MM,Zhang Y,et al. Comparative study of clinical efficacy between preoperative and postoperative intensity-modulated radiotherapy with oral capecitabine in low rectal cancer[J].Chin J Radiat Oncol,2010,19(1):72-73.DOI:10.3760/cma.j.issn.1004-4221.2010.01.027.
[17]Li JL,Ji JF,Cai Y,et al. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer:a phase Ⅱ trial[J].Radiother Oncol,2012,102(1):4-9.DOI:10.1016/j.radonc.2011.07.030.
[18]Yang YQ,Feng LCH,Jia QB,et al. Preliminary results of the prospective clinical trial of preoperative concomitant boost intensity-modulated radiotherapy in locally advanced rectal cancer[J].Chin J Radiol Med Prot,2013,33(5):512-515.DOI:10.3760/cma.j.issn.0254-5098.2013.05.014.
[19]Xiao L,Huang R,You KY,et al. Study on feasibility of preoperative neoadjuvant chemoradiotherapy based on volumetric modulated arc therapy for locally advanced rectal cancer[J].Chin J Radiat Oncol,2014,23(1):9-13.DOI:10.3760/cma.j.issn.1004-4221.2014.01.003.
[20]杨咏强,冯林春,王运来,等.VMAT应用于直肠癌术前同期加量放疗的剂量学研究[J].中华放射肿瘤学杂志,2014,23(5):400-401.DOI:10.3760/cma.j.issn.1004-4221.2014.05.008.
Yang YQ,Feng LCH,Wang YL,et al. Dosimetric study of preoperative volumetric intensity-modulated arc therapy for rectal cancer[J].Chin J Radiat Oncol,2014,23(5):400-401.DOI:10.3760/cma.j.issn.1004-4221.2014.05.008.
[21]Zhu J,Liu FQ,Gu WL,et al. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage Ⅱ/Ⅲ rectal adenocarcinoma:results of a phase Ⅱ study[J].Radiat Oncol,2014,9(1):70.DOI:10.1186/1748-717X-9-70.
[22]Hernando-Requejo O,López M,Cubillo A,et al. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation[J].Strahlenther Onkol,2014,190(6):515-520.DOI:10.1007/s00066-014-0650-0.
[23]Baglan KL,Frazier RC,Yan D,et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2002,52(1):176-183.DOI:10.1016/S0360-3016(01)01820-X.
[24]Robertson JM,Shn M,Yan D,et al. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model[J].Int J Radiat Oncol Biol Phys,2010,77(1):66-72.DOI:10.1016/j.ijrobp.2009.04.048.
[25]Wong SJ,Winter K,Meropol NJ,et al. Radiation Therapy Oncology Group 0247:a randomized phase Ⅱ study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer[J].Int J Radiat Oncol Biol Phys,2012,82(4):1367-1375.DOI:10.1016/j.ijrobp.2011.05.027.
[26]Capirci C,Valentini V,Cionini L,et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer:long-term analysis of 566 ypCR patients[J].Int J Radiat Oncol Biol Phys,2008,72(1):99-107.DOI:10.1016/j.ijrobp.2007.12.019.
[27]Zorcolo L,Rosman AS,Restivo A,et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival:a meta-analysis[J].Ann Surg Oncol,2012,19(9):2822-2832.DOI:10.1245/s10434-011-2209-y.
[28]Maas M,Beets-Tan RGH,Lambregts DMJ,et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer[J].J Clin Oncol,2011,29(35):4633-4640.DOI:10.1200/JCO.2011.37.7176.
[29]Habr-Gama A,Gama-Rodrigues J,S o Juli o GP,et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation:impact of salvage therapy on local disease control[J].Int J Radiat Oncol Biol Phys,2014,88(4):822-828.DOI:10.1016/j.ijrobp.2013.12.012.
[30]Fu CG,Gao XH.Surgical treatment strategies for locally advanced rectal cancer after neoadjuvant radiation[J].Chin J Gastroint Surg,2013,16(6):513-517.DOI:10.3760/cma.j.issn.1671-0274.2013.06.005.
[31]Mohiuddin M,Regine WF,John WJ,et al. Preoperative chemoradiation in fixed distal rectal cancer:dose time factors for pathological complete response[J].Int J Radiat Oncol Biol Phys,2000,46(4):883-888.DOI:10.1016/S0360-3016(99)00486-1.
[32]Wiltshire KL,Ward IG,Swallow C,et al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer:effect of dose escalation on pathologic complete response,local recurrence-free survival,disease-free survival,and overall survival[J].Int J Radiat Oncol Biol Phys,2006,64(3):709-716.DOI:10.1016/j.ijrobp.2005.08.012. |
|
|
|
2016, Vol. 25 
